Annual Secretarial Compliance Report for FY ended 31.03.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bandaram Pharma Packtech Ltd has filed its Annual Secretarial Compliance Report for FY 2025-26 under SEBI Regulation 24A. The report by PCS firm Manoj Parakh & Associates confirms the company is largely compliant with applicable SEBI regulations including LODR 2015, Insider Trading Regulations, and Depositories Regulations. Two observations were noted: (1) BSE had issued a clarification letter on 02.12.2025 regarding unusual price movement, which the company attributed to normal market activity with no undisclosed price-sensitive information, and (2) a prior-year related party transaction (RPT) filing for H2 ended March 2024 was delayed by one day due to a technical glitch, for which a fine was paid and the matter was resolved. No additional non-compliances were observed during the review period.
The company has demonstrated general compliance with SEBI regulations. The minor RPT filing delay from the previous year has been resolved with a fine paid, which is unlikely to materially impact the stock. The BSE price movement clarification appears routine.